arrow
J

José M. Mato

ciberehd
H-index:89
Citation Count:2.7万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis

ARF GTPase蛋白1的小分子抑制剂限制了肝癌和结肠癌细胞的生长和转移

2026-02-200
OAAI
Methionine Adenosyltransferase 1A and S-Adenosylmethionine in Alcohol-Associated Liver Disease

蛋氨酸腺苷转移酶1A和S-腺苷蛋氨酸在酒精性肝病中的作用

2025-12-110
OAAI
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction

脂蛋白(a)、肝脏损伤和血管损伤在代谢功能障碍个体中的相互作用

2025-11-260
OAAI
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohorts

年龄和性别特异的脂蛋白谱在一般和心血管代谢人群队列中的研究

2025-11-080
OAAI
Multi-omic integration sets the path for early prevention strategies on healthy individuals

多组学整合为针对健康个体的早期预防策略奠定了基础。

2025-05-030
OAAI
S-adenosylmethionine deficit disrupts very low-density lipoprotein metabolism promoting liver lipid accumulation in mice

S-腺苷甲硫氨酸缺乏会破坏极低密度脂蛋白代谢,促进小鼠肝脏脂质积累。

2025-05-010
OAAI
Enhanced Standard Operating Procedures for 31P NMR-Based Metabolomics in Tissue Extracts

基于31P NMR的代谢组学在组织提取物中的增强型标准操作规程

JACS AU
IF8.7
2025-04-130
OA
Fructose-induced progression of steatohepatitis involves disrupting aldolase B-AMPK signaling in methionine adenosyltransferase 1A deficient mice
2025-04-010
PRE
Management of drug-induced liver injury associated with anti-cancer therapy

抗肿瘤治疗相关药物性肝损伤的管理

2025-03-270
OA
Multi-Omics Biomarkers for Predicting Therapeutic Efficacy in Inflammatory Bowel Disease: Advancing Towards Tailored Treatments
2025-01-220
PRE
Identification of metabolic predictive biomarkers of response to Inflammatory Bowel Disease treatment
2025-01-220
PRE
Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models
2024-10-010
PRE
The role of forkhead box M1-methionine adenosyltransferase 2 A/2B axis in liver inflammation and fibrosis
2024-09-270
OAAI
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
2024-09-260
PRE
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
2024-07-240
OAAI
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA
Hepatic prohibitin 1 and methionine adenosyltransferase a1 defend against primary and secondary liver cancer metastasis
2024-03-013
PRE
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
2023-09-018
OAAI
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
2023-07-2423
OAAI
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
2023-02-1523
OAAI